Maskens AP - Search Results

1

Phase II trial of bleomycin in patients with advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group Study.

Vermorken JB, Armand JP, Lacave AJ, George M, de Oliveira CF, Cheix F, Maskens AP, Rotmensz N. Vermorken JB, et al. Among authors: maskens ap. Eur J Cancer Clin Oncol. 1985 Jun;21(6):671-3. doi: 10.1016/0277-5379(85)90263-9. Eur J Cancer Clin Oncol. 1985. PMID: 2410278

2

Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group Study.

Hamerlynck JV, Maskens AP, Mangioni C, van der Burg ME, Wils JA, Vermorken JB, Rotmensz N. Hamerlynck JV, et al. Among authors: maskens ap. Gynecol Oncol. 1985 Nov;22(3):313-6. doi: 10.1016/0090-8258(85)90045-9. Gynecol Oncol. 1985. PMID: 2998957

3

Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group Study.

de Oliveira CF, Lacave AJ, Villani C, Wolff JP, di Re F, Namer M, Maskens A, George M, Dalesio O, Rotmensz N, et al. de Oliveira CF, et al. Eur J Gynaecol Oncol. 1990;11(5):323-30. Eur J Gynaecol Oncol. 1990. PMID: 2097149 Clinical Trial.

4

Phase II clinical trial of VP-16-213 in ovarian cancer.

Maskens AP, Armand JP, Lacave AJ, De Jager RL, Hansen HH, Wolff JP. Maskens AP, et al. Cancer Treat Rep. 1981 Mar-Apr;65(3-4):329-30. Cancer Treat Rep. 1981. PMID: 7016320 Clinical Trial. No abstract available.

5

Significance of the labeling index and labeling distribution as kinetic parameters in colorectal mucosa of cancer patients and DMH treated animals.

Deschner EE, Maskens AP. Deschner EE, et al. Among authors: maskens ap. Cancer. 1982 Sep 15;50(6):1136-41. doi: 10.1002/1097-0142(19820915)50:6<1136::aid-cncr2820500617>3.0.co;2-a. Cancer. 1982. PMID: 7104954 No abstract available.

6

Confirmation of the two-step nature of chemical carcinogenesis in the rat colon adenocarcinoma model.

Maskens AP. Maskens AP. Cancer Res. 1981 Mar;41(3):1240-5. Cancer Res. 1981. PMID: 7459865

7

Experimental adenomas and carcinomas of the large intestine behave as distinct entities: most carcinomas arise de novo in flat mucosa.

Maskens AP, Dujardin-Loits RM. Maskens AP, et al. Cancer. 1981 Jan 1;47(1):81-9. doi: 10.1002/1097-0142(19810101)47:1<81::aid-cncr2820470115>3.0.co;2-t. Cancer. 1981. PMID: 7006791 Review.

8

Relationship between dose, time, and tumor yield in mouse dimethylhydrazine-induced colon tumorigenesis.

Deschner EE, Long FC, Maskens AP. Deschner EE, et al. Among authors: maskens ap. Cancer Lett. 1979 Nov;8(1):23-8. doi: 10.1016/0304-3835(79)90018-1. Cancer Lett. 1979. PMID: 509415

9

Tritiated thymidine incorporation into epithelial cells of normal-appearing colorectal mucosa of cancer patients.

Maskens AP, Deschner EE. Maskens AP, et al. J Natl Cancer Inst. 1977 May;58(5):1221-4. doi: 10.1093/jnci/58.5.1221. J Natl Cancer Inst. 1977. PMID: 853522

10

Significance of the karyorrhectic index in 1,2-dimethylhydroazine carcinogenesis.

Maskens AP. Maskens AP. Cancer Lett. 1979 Nov;8(1):77-86. doi: 10.1016/0304-3835(79)90026-0. Cancer Lett. 1979. PMID: 509422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters